Although no significant difference was found between the pre-clinical HF group and the pre-clinical HF+T2DM group (P = 0.62), the HF+T2DM group had lower levels of serum sFRP2 than the HF group (P <0.0001). The gene discussed is SFRP2; the disease is hydrops fetalis.